Skip to Main Content

Paper Details

Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
Lancet HIV,The
171
2015
Atorvastatin, FDG, HIV, HIV-infected, LDL-cholesterol, Statin, arterial inflammation, arterial inflammation of the aorta, atherosclerosis, atorvastatin, cholesterol, coronary, coronary artery, coronary artery disease, coronary atherosclerosis, fluorodeoxyglucose, lipoprotein-associated phospholipase A2, myocardial infarction, participants, patients, people, statin
Author NameAffiliation
Gregory K RobbinsMassachusetts General Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2